Cite
Sato Y, Bernier F, Yamanaka Y, et al. Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease. Alzheimers Dement (Amst). 2015;1(1):67-74doi: 10.1016/j.dadm.2014.11.009.
Sato, Y., Bernier, F., Yamanaka, Y., Aoshima, K., Oda, Y., Ingelsson, M., Lannfelt, L., Miyashita, A., Kuwano, R., & Ikeuchi, T. (2015). Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 1(1), 67-74. https://doi.org/10.1016/j.dadm.2014.11.009
Sato, Yoshiaki, et al. "Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 1,1 (2015): 67-74. doi: https://doi.org/10.1016/j.dadm.2014.11.009
Sato Y, Bernier F, Yamanaka Y, Aoshima K, Oda Y, Ingelsson M, Lannfelt L, Miyashita A, Kuwano R, Ikeuchi T. Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease. Alzheimers Dement (Amst). 2015 Mar 29;1(1):67-74. doi: 10.1016/j.dadm.2014.11.009. eCollection 2015 Mar. PMID: 27239493; PMCID: PMC4876914.
Copy
Download .nbib